Gerardo Ongari

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

Claudio Giuliano, Miriam Francavilla, Gerardo Ongari et al. · International Journal of Molecular Sciences · 2021 · 67 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Profiling the Biochemical Signature of GBA‐Related Parkinson's Disease in Peripheral Blood Mononuclear Cells

Micol Avenali, Silvia Cerri, Gerardo Ongari et al. · Movement Disorders · 2021 · 40 citations · Full text

Life Sciences, Biochemistry, Neurology +16

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol

Fabiana Colucci, Micol Avenali, Rosa De Micco et al. · BMJ Neurology Open · 2023 · 32 citations · Full text

Medicine, Neurology, Pharmacology +17

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease

Silvia Cerri, Cristina Ghezzi, Gerardo Ongari et al. · International Journal of Molecular Sciences · 2021 · 31 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Impaired Mitochondrial Respiration in <scp>REM</scp>‐Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?

Gerardo Ongari, Cristina Ghezzi, D. Di Martino et al. · Movement Disorders · 2023 · 14 citations · Full text

Life Sciences, Neurology, Neuroscience +17